BMJ 1994;308:74-5 (8 January)

Editorials

IgA nephropathy

Since idiopathic IgA nephropathy was first reported a quarter of a century ago it has evolved from being a curiosity to becoming the commonest form of glomerulonephritis in industrialised countries. A recent international meeting held to mark the 25 years of study of IgA nephropathy concentrated on its aetiology and pathogenesis but had also to acknowledge that nephrologists still do not know how to treat the disease.1

Clinical observation over two decades has shown that spontaneous remission may occur but that 15-20% of patients develop end stage renal failure within 10 years of diagnosis. The risk factors for progression are impaired renal function at presentation, heavy proteinuria, hypertension, and (curiously) absence of the typical symptom - recurrent macroscopic haematuria. The systemic nature of IgA nephropathy is shown convincingly by its recurrence in patients who receive a kidney transplant and, more remarkably, by the disappearance of IgA deposits when a kidney . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Sediva, A., Smetana, K. Jr., Stejskal, J., Bartunkova, J., Liu, F.-T., Bovin, N. V., Gabius, H.-J. (1999). Binding sites for carrier-immobilized carbohydrates in the kidney: implication for the pathogenesis of Henoch-Schonlein purpura and/or IgA nephropathy. Nephrol Dial Transplant 14: 2885-2891 [Abstract] [Full text]  
  • Piette, W. W. (1997). What Is Schonlein-Henoch Purpura, and Why Should We Care?. Arch Dermatol 133: 515-518 [Abstract]  
Access jobs at BMJ Careers
Whats new online at Student BMJ